Por favor, use este identificador para citar o enlazar este ítem:
http://conacyt.repositorioinstitucional.mx/jspui/handle/1000/8736
Respiratory Failure in Covid19 is associated with increased monocyte expression of complement receptor 3 | |
Rajeev Gupta vanya gant Bryan Williams Tariq Enver | |
Acceso Abierto | |
Atribución-NoComercial-SinDerivadas | |
https://doi.org/10.1101/2020.05.31.20118638 | |
https://www.medrxiv.org/content/10.1101/2020.05.31.20118638v1 | |
A key question in COVID-19 infection is why some previously healthy patients develop severe pulmonary failure and some ultimately die. Initial pulmonary failure does not exhibit classical features of ARDS; hypercoagulability is a common laboratory feature, and pulmonary thrombotic microangiopathy has been reported post mortem1,2,3. Biomarkers cannot robustly identify such patients pre-emptively and no specific interventions exist to mitigate clinical deterioration. Mononuclear phagocytic cells are key immune cells and bind fibrinogen through the CD11b/CD18 dimer CR3, whose activated form can initiate microthrombus formation. Accordingly, we profiled circulating monocyte CD11b/CD18 cell surface density from COVID-19 infected adults who were (i) symptomatic but breathless, (ii) requiring ventilatory support, and (iii) recovering following ICU care for hypoxia. | |
bioRxiv | |
02-06-2020 | |
Preimpreso | |
Inglés | |
Público en general | |
VIRUS RESPIRATORIOS | |
Versión publicada | |
publishedVersion - Versión publicada | |
Aparece en las colecciones: | Materiales de Consulta y Comunicados Técnicos |
Cargar archivos:
Fichero | Tamaño | Formato | |
---|---|---|---|
Respiratory Failure in Covid19 is associated with increased monocyte expression of complement receptor 3.pdf | 186.67 kB | Adobe PDF | Visualizar/Abrir |